Jonathan LanfearGlobal Head, R&D Business Development at Takeda Pharmaceuticals International, Inc
Jonathan Lanfear is the Vice President and Global Head of Oncology & Neuroscience Business Development at Takeda Pharmaceuticals International and is based in Cambridge, MA. Prior to joining Takeda, Mr. Lanfear spent approximately 8 years at Pfizer Inc as a Transactions Lead in the Worldwide Business Development, Strategy, & Innovation (WWBDS&I) organization based in New York. His time at Pfizer was preceded by AG Edwards/Wachovia, where he guided Biotechnology Equity Research coverage and participated in public offerings of several blue-chip Biotechnology stocks. Prior to joining AG Edwards, Jonathan spent several years in Business Development at Searle/Pharmacia where he worked on a number of key licensing transactions prior to the company’s acquisition. Over his ~25-year career in the industry, Mr. Lanfear has lead hundreds of transactions of all types, integrated acquired entities, and managed strategic alliances/partnerships. He holds a Bachelors degree in Chemical Engineering and a Master’s degree in Bioengineering, both from the University of Michigan, along with an MBA from Washington University.